Mark J. Messing, MD

Gynecological Oncology in Irving, TX

2021 N Macarthur Blvd, Suite 400, Irving, TX 75061 · Texas Oncology PA
NPI 1932141033 Accepts Medicare assignment Offers telehealth 42 years since graduation Public record — not managed by the clinician

About Dr. Mark Messing

Dr. Mark Messing is a physician specializing in gynecological oncology practicing in Irving, TX, a graduate of Emory University School of Medicine (1984). Affiliated with Baylor Scott & White Medical Center Grapevine, Methodist Southlake Medical Center, Texas Health Heb. Treated 130 Medicare patients in 2024.

SpecialtyGynecological OncologyOther gynecological oncology doctors in Irving
CredentialsMD
EducationEmory University School of Medicine, 1984CMS Doctors and Clinicians
GenderMale
NPI number1932141033National Provider Identifier (CMS NPPES), issued June 2006
MedicareEnrolled in Medicare; accepts Medicare assignment (the Medicare-approved amount as full payment)CMS Doctors and Clinicians
TelehealthOffers telehealth servicesCMS Doctors and Clinicians

Where Dr. Mark Messing practices

Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.

Dr. Mark Messing's specialties and state licenses

Specialty (NPPES)License
Gynecologic Oncology PrimaryTX H7467

As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.

Hospital affiliations of Dr. Mark Messing

  • Baylor Scott & White Medical Center GrapevineHospital · Grapevine, TX
  • Methodist Southlake Medical CenterHospital · Southlake, TX
  • Texas Health HebHospital · Bedford, TX

CMS Facility Affiliation data: facilities where the clinician bills Medicare.

Dr. Mark Messing's Medicare patients and services (2024)

130Medicare patients
2,057services billed
75average patient age
100%women

Most frequent services

ServiceTimesAvg. Medicare allowed
Insertion of needle into vein for collection of blood sample229$8.65
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count195$7.61
Blood test, comprehensive group of blood chemicals178$10.35
Immunologic analysis for detection of tumor antigen, quantitative; ca 125154$20.39
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more137$125.87
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more110$89.32
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's45$16.05
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more19$163.89

Common conditions among these patients

  • High cholesterol75%
  • High blood pressure73%
  • Cancer50%
  • Arthritis48%
  • Chronic kidney disease28%
  • Diabetes25%

Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.

Dr. Mark Messing's Medicare quality score (MIPS 2024)

85.1/100final MIPS score
67.5quality
100promoting interoperability
40improvement activities

The Merit-based Incentive Payment System scores clinicians who bill Medicare. Reported as apm. Source: CMS Care Compare, PY 2024 clinician public reporting.

Payments from drug and device companies to Dr. Mark Messing (2025)

$186.26 in 5 general payments reported in 2025.

TypePaymentsAmount
Food and beverage5$186.26

Paying companies: Myriad Genetic Laboratories, Inc. ($105.98), Sobi, Inc ($35.68), Servier Pharmaceuticals LLC ($24.98), Merck Sharp & Dohme LLC ($19.62).

Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.

Questions about Dr. Mark Messing

What kind of clinician is Dr. Mark Messing?

Dr. Mark Messing is listed as a physician specializing in gynecological oncology.

Where does Dr. Mark Messing practice?

Texas Oncology PA at 2021 N Macarthur Blvd, Suite 400, Irving, TX 75061.

What is the office phone number for Dr. Mark Messing?

The listed office number is (972) 256-3537. Call to confirm availability and whether new patients are accepted.

What is the NPI number of Dr. Mark Messing?

The National Provider Identifier is 1932141033.

Does Dr. Mark Messing accept Medicare?

Yes. CMS lists this clinician as accepting Medicare assignment. Confirm your plan with the office.

Which hospitals is Dr. Mark Messing affiliated with?

Baylor Scott & White Medical Center Grapevine, Methodist Southlake Medical Center, Texas Health Heb.

Where did Dr. Mark Messing go to medical school?

Emory University School of Medicine, graduating in 1984.

Where this information comes from

CMS Doctors and CliniciansName, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026)
NPPES NPI registryNPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2013-05-08
Facility affiliationsHospitals and other facilities.CMS Doctors and Clinicians facility affiliation file; names from CMS Provider of Services
Medicare utilizationPatients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024
MIPSQuality payment program scores.CMS clinician public reporting, PY 2024
Open PaymentsPayments from drug and device companies.CMS Open Payments, program year 2025

Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.

0 clinics selected Compare